Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Shares Issued (2018 - 2024)

BioNexus Gene Lab's Shares Issued history spans 3 years, with the latest figure at $1064.0 for Q4 2024.

  • For Q4 2024, Shares Issued changed N/A year-over-year to $1064.0; the TTM value through Dec 2024 reached $2650.0, up 100.53%, while the annual FY2024 figure was $79851.0, N/A changed from the prior year.
  • Shares Issued for Q4 2024 was $1064.0 at BioNexus Gene Lab, down from $1586.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $1586.0 in Q3 2024 and bottomed at $1064.0 in Q4 2024.